<PAGE>
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
-----------------
FORM 10-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
April 2, 1997
--------------------
Date of Report
(Date of earliest event reported)
ELECTROPHARMACOLOGY, INC.
-------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 0-25828 95-4315412
- ------------------------------- ----------------------- --------------------
(State or other Jurisdiction of (Commission File Number) (I.R.S. Employer
Incorporation) Identification No.)
2301 N.W. 33rd Court, Suite 102
Pompano Beach, Florida 33069
- ------------------------------- --------------------
(Address of Principal Executive (Zip Code)
Offices)
(954) 975-9818
----------------------------------------------------
(Registrant's telephone number, including area code)
<PAGE>
ITEM 5. OTHER EVENTS.
Electropharmacology, Inc. (the "Registrant") announced on April 2, 1997 the
resignation of Joseph Mooibroek, the Registrant's Chairman of the Board,
President and Chief Executive Officer, effective immediately, and the
appointment of Dr. Arup Sen as the Registrant's Chairman of the Board, President
and Chief Executive Officer. Dr. Sen previously was the Registrant's Executive
Vice President of Research, Development, Regulatory and Clinical Studies.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Electropharmacology, Inc.
By: /s/ ARUP SEN
-------------------------
Arup Sen
President and Chief Executive Officer
April 2, 1997
